.After F2G's 1st attempt to obtain a new course of antifungal to market was derailed due to the FDA,...
.Moderna has actually sworn to cut R&D spending through $1.1 billion by 2027. The choice to shrin...
.Only four months after Sanofi wager $80 million in ahead of time cash on Fulcrum Rehabs' losmapimod...
.Cancer cells company Oncternal Therapeutics is folding all its own scientific tests and giving up p...
.Roche is keeping out hopes that its own injectable being overweight prospect might ultimately show ...
.Novo Nordisk has actually elevated the cover on a phase 1 test of its dental amylin and also GLP-1 ...
.Only a handful of brief weeks after winning an FDA Fast lane tag for its investigational BTK degrad...
.Soon after a good information drop for Eli Lilly's efsitora alfa, the Indianapolis-based firm is ac...
.BridgeBio Pharma is actually lowering its gene treatment budget plan and pulling back coming from t...
.GSK's effort to develop the initial injection for herpes simplex infection (HSV) has actually finis...